Trinadha Rao Chitturi

This inventor holds 18 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Research. Top assignees: Sun Pharma Advanced Research Company Limited, Sun Pharmaceutical Industries Limited. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Trinadha Rao Chitturi. Retrieved from https://idiyas.com/inventor/trinadha-rao-chitturi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 61.1

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 42(Granted Patents)

Location History:

Andhra Pradesh, IN (2003)
Akota, IN (2008)
Vadodara, IN (2021 - 2022)
Baroda, IN (2002 - 2023)

Company Filing History:

11 out of 66

Sun Pharma Advanced Research Company Limited

patents

7 out of 157

Sun Pharmaceutical Industries Limited

patents

Years Active: 2002-2023

Loading Chart...

Areas of Expertise:

Parkinson's Disease

Antiestrogens

Malic Enzyme Inhibitors

Selective Estrogen Receptor Degrader

Tyrosine Kinase Inhibitors

Chiral Beta Amino Carboxamide

Fluvoxamine Maleate

Stereoisomers Conversion

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11813252 - Treatment for Parkinson's disease (2023-11-14),

2. 11583522 - Treatment for Parkinson's disease (2023-02-21),

3. 11465990 - Heterocyclic antiestrogens (2022-10-11),

4. 11225480 - Malic enzyme inhibitors (2022-01-18),

5. 11014915 - Selective estrogen receptor degrader (2021-05-25),

6. 10865199 - Heterocyclic antiestrogens (2020-12-15),

7. 10849887 - Treatment of Parkinson's disease (2020-12-01),

8. 10179800 - Crystalline forms of S-[4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl] 6-α,9-α-difluoro-17-α-(furan-2-yl)carbonyloxy-11-β-hydroxy-16-α-methyl-3-oxoandrosta-1,4-diene-17-β-carbothioate (2019-01-15),

9. 9024021 - Diarylacetylene hydrazide containing tyrosine kinase inhibitors (2015-05-05),

10. 8785425 - 11β-hydroxyandrosta-4-ene-3-ones (2014-07-22),

11. 8471016 - Process for the preparation of chiral beta amino carboxamide derivatives (2013-06-25),

12. 8133888 - Hydrazide containing taxane conjugates (2012-03-13),

13. 7678908 - Process of preparing desaloratadine (2010-03-16),

14. 7411087 - Process for preparation of bisphosphonic acid compounds (2008-08-12),

15. 7297697 - 4-(diarylmethyl)-1-piperazinyl derivatives (2007-11-20),

Title: The Innovative Mind of Trinadha Rao Chitturi

Introduction

Trinadha Rao Chitturi is a prominent inventor based in Baroda, India, known for his significant contributions to the field of medical research. With an impressive portfolio of 18 patents, his work primarily focuses on innovative treatments for neurological disorders, including Parkinson's disease.

Latest Patents

Among his latest inventions is a groundbreaking method for treating or preventing Parkinson's disease. This invention involves a detailed approach that administers a compound of Formula I to affected subjects. Chitturi's innovative method aims to enhance the quality of life for individuals suffering from this debilitating condition.

Career Highlights

Chitturi has had a fruitful career, marked by his tenure at notable pharmaceutical companies. He worked at Sun Pharma Advanced Research Company Limited and Sun Pharmaceutical Industries Limited, where he applied his expertise to drive advancements in pharmaceutical innovation.

Collaborations

Throughout his career, Trinadha Rao Chitturi collaborated with several esteemed professionals, including Rajamannar Thennati and Kanaksinh Jesingbhai Jadav. These collaborations have enriched his research and contributed to the successful development of his patents.

Conclusion

Trinadha Rao Chitturi's work exemplifies the spirit of innovation within the realm of medical research. His contributions, particularly to Parkinson's disease treatment, highlight the potential of inventive minds to create solutions that can impact lives positively. As he continues his journey, the medical and scientific communities look forward to his future innovations and the benefits they may bring.

Profile summary based on public USPTO records.